Kirsten Harmrolfs

1.9k total citations · 1 hit paper
32 papers, 1.4k citations indexed

About

Kirsten Harmrolfs is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Kirsten Harmrolfs has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 15 papers in Molecular Biology and 11 papers in Organic Chemistry. Recurrent topics in Kirsten Harmrolfs's work include Microbial Natural Products and Biosynthesis (19 papers), Antibiotic Resistance in Bacteria (5 papers) and Synthetic Organic Chemistry Methods (5 papers). Kirsten Harmrolfs is often cited by papers focused on Microbial Natural Products and Biosynthesis (19 papers), Antibiotic Resistance in Bacteria (5 papers) and Synthetic Organic Chemistry Methods (5 papers). Kirsten Harmrolfs collaborates with scholars based in Germany, United States and Spain. Kirsten Harmrolfs's co-authors include Rolf Müller, Andreas Kirschning, Nataliya Gorinski, Christina Hesse, Christin Friedrich, Sarah K. Tschirner, Matthias Lochner, Carla N. Castro, Heike Bähre and Luciana Berod and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Kirsten Harmrolfs

32 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells

2014 700 citations Luciana Berod, Christin Friedrich et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirsten Harmrolfs Germany	19	626	474	400	201	163	32	1.4k
Il‐Seon Park South Korea	26	1.1k 1.7×	241 0.5×	105 0.3×	109 0.5×	81 0.5×	57	1.7k
Byung Woo Han South Korea	24	1.2k 1.8×	250 0.5×	103 0.3×	271 1.3×	46 0.3×	99	1.8k
TAKAYUKI NAITÔ United Kingdom	18	744 1.2×	304 0.6×	413 1.0×	477 2.4×	90 0.6×	72	1.7k
Fatemeh Mosaffa Iran	26	1.0k 1.7×	249 0.5×	172 0.4×	351 1.7×	36 0.2×	86	1.9k
Alessandra Tosco Italy	25	1.0k 1.7×	160 0.3×	156 0.4×	175 0.9×	66 0.4×	75	1.6k
Jeong‐Heon Ko South Korea	20	1.1k 1.8×	225 0.5×	85 0.2×	74 0.4×	74 0.5×	41	1.6k
Yi Kong China	20	712 1.1×	102 0.2×	191 0.5×	58 0.3×	89 0.5×	96	1.4k
Shigeru Hoshiko Japan	15	386 0.6×	134 0.3×	202 0.5×	88 0.4×	82 0.5×	30	851
Dale T. Blankenship United States	21	997 1.6×	144 0.3×	201 0.5×	79 0.4×	109 0.7×	26	1.8k

Countries citing papers authored by Kirsten Harmrolfs

Since Specialization

Citations

This map shows the geographic impact of Kirsten Harmrolfs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten Harmrolfs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten Harmrolfs more than expected).

Fields of papers citing papers by Kirsten Harmrolfs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten Harmrolfs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten Harmrolfs. The network helps show where Kirsten Harmrolfs may publish in the future.

Co-authorship network of co-authors of Kirsten Harmrolfs

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten Harmrolfs. A scholar is included among the top collaborators of Kirsten Harmrolfs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten Harmrolfs. Kirsten Harmrolfs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tegge, Werner, Chunfa Xu, Kirsten Harmrolfs, et al.. (2024). A Targeted Click‐to‐Release Activation of the Last‐Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. Angewandte Chemie International Edition. 63(47). e202408360–e202408360. 3 indexed citations

Harmrolfs, Kirsten, et al.. (2023). Siderophore conjugation with cleavable linkers boosts the potency of RNA polymerase inhibitors against multidrug-resistantE. coli. Chemical Science. 14(20). 5490–5502. 12 indexed citations

Harmrolfs, Kirsten, Chantal D. Bader, Ronald Garcia, et al.. (2022). Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA‐Virus Inhibitors**. Angewandte Chemie International Edition. 61(52). e202212946–e202212946. 18 indexed citations

Tegge, Werner, Ulrike Beutling, Kirsten Harmrolfs, et al.. (2021). Selective Bacterial Targeting and Infection‐Triggered Release of Antibiotic Colistin Conjugates. Angewandte Chemie International Edition. 60(33). 17989–17997. 17 indexed citations

Ding, Wei, Emilia Oueis, María García‐Altares, et al.. (2018). Two Types of Threonine-Tagged Lipopeptides Synergize in Host Colonization by Pathogenic Burkholderia Species. ACS Chemical Biology. 13(5). 1370–1379. 35 indexed citations

Steinmetz, Heinrich, Jun Li, Chengzhang Fu, et al.. (2016). Isolation, Structure Elucidation, and (Bio)Synthesis of Haprolid, a Cell‐Type‐Specific Myxobacterial Cytotoxin. Angewandte Chemie International Edition. 55(34). 10113–10117. 23 indexed citations

Koutsoudakis, George, Inés Romero‐Brey, Carola Berger, et al.. (2015). Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity. Journal of Hepatology. 63(4). 813–821. 28 indexed citations

Polak, Tomaž, Martin Šala, Kirsten Harmrolfs, et al.. (2015). Construction of a New Class of Tetracycline Lead Structures with Potent Antibacterial Activity through Biosynthetic Engineering. Angewandte Chemie International Edition. 54(13). 3937–3940. 40 indexed citations

Baumann, Sascha, Jennifer Herrmann, Ritesh Raju, et al.. (2014). Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity. Angewandte Chemie International Edition. 53(52). 14605–14609. 138 indexed citations

10.

Berod, Luciana, Christin Friedrich, Amrita Nandan, et al.. (2014). De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nature Medicine. 20(11). 1327–1333. 700 indexed citations breakdown →

11.

Harmrolfs, Kirsten, Stefan E. Heiden, Christoph Wiesner, et al.. (2014). Anti-MRSA-acting carbamidocyclophanes H–L from the Vietnamese cyanobacterium Nostoc sp. CAVN2. The Journal of Antibiotics. 68(3). 165–177. 33 indexed citations

12.

Tang, Ying, Kirsten Harmrolfs, Jennifer Herrmann, et al.. (2014). Heterologous expression of an orphan NRPS gene cluster from Paenibacillus larvae in Escherichia coli revealed production of sevadicin. Journal of Biotechnology. 194. 112–114. 18 indexed citations

13.

Harmrolfs, Kirsten, et al.. (2014). Preparation of new alkyne-modified ansamitocins by mutasynthesis. Beilstein Journal of Organic Chemistry. 10. 535–543. 19 indexed citations

14.

Viehrig, Konrad, Frank Surup, Kirsten Harmrolfs, et al.. (2013). Concerted Action of P450 Plus Helper Protein To Form the Amino-hydroxy-piperidone Moiety of the Potent Protease Inhibitor Crocapeptin. Journal of the American Chemical Society. 135(45). 16885–16894. 28 indexed citations

15.

Katsuyama, Yohei, et al.. (2012). Eine Semipinakol‐Umlagerung – katalysiert durch ein Enzymsystem mit difunktioneller FAD‐abhängiger Monooxygenase. Angewandte Chemie. 124(37). 9573–9576. 5 indexed citations

16.

Knobloch, Tobias, et al.. (2011). Mutational Biosynthesis of Ansamitocin Antibiotics: A Diversity‐Oriented Approach to Exploit Biosynthetic Flexibility. ChemBioChem. 12(4). 540–547. 29 indexed citations

17.

Taft, Florian, Kirsten Harmrolfs, Miriam Kiene, et al.. (2011). Combined Muta‐ and Semisynthesis: A Powerful Synthetic Hybrid Approach to Access Target Specific Antitumor Agents Based on Ansamitocin P3. Chemistry - A European Journal. 18(3). 880–886. 23 indexed citations

18.

Knobloch, Tobias, Heinz G. Floss, Jörg Fohrer, et al.. (2011). The Interplay between Mutasynthesis and Semisynthesis: Generation and Evaluation of an Ansamitocin Library. Angewandte Chemie International Edition. 51(3). 752–757. 35 indexed citations

19.

Harmrolfs, Kirsten, Gerald Dräger, Heinz G. Floss, et al.. (2010). Cyclization of Synthetic seco‐Proansamitocins to Ansamitocin Macrolactams by Actinosynnema pretiosum as Biocatalyst. ChemBioChem. 11(18). 2517–2520. 15 indexed citations

20.

Kirschning, Andreas, Kirsten Harmrolfs, & Tobias Knobloch. (2008). The chemistry and biology of the maytansinoid antitumor agents. Comptes Rendus Chimie. 11(11-12). 1523–1543. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact